Literature DB >> 27552092

Histopathologic Features of Prognostic Significance in High-Grade Osteosarcoma.

Michael Herman Chui, Rita A Kandel, Marcus Wong, Anthony M Griffin, Robert S Bell, Martin E Blackstein, Jay S Wunder, Brendan C Dickson.   

Abstract

Context .- In osteosarcoma treated with neoadjuvant chemotherapy the extent of tumor necrosis on resection is considered an indicator of treatment response, and this has been shown to correlate with survival in most but not all studies. Objective .- To identify additional histologic variables of prognostic significance in high-grade osteosarcoma. Design .- Slides of pretreatment biopsy and primary postneoadjuvant chemotherapy resections from 165 patients with high-grade osteosarcoma were reviewed. Univariate (Kaplan-Meier) and multivariate (Cox regression) analyses were performed to identify clinical and histomorphologic attributes associated with overall survival. Results .- Univariate analyses confirmed the prognostic significance of metastatic status on presentation, primary tumor size, anatomic site, and histologic subtype. Additionally, the identification of lymphovascular invasion, 10% or more residual viable tumor, and 10 or more mitoses per 10 high-powered fields assessed in posttreatment resections were associated with poor survival, retaining significance in multivariate analyses. Based on results from multivariate analysis, we developed a prognostic index incorporating primary tumor size and site, and significant histologic features assessed on resection (ie, lymphovascular invasion status, mitotic rate, and extent of viable tumor). This scoring system segregates patients into 3 risk categories with significant differences in overall survival and retained significance in an independent validation set of 42 cases. Conclusions .- The integration of clinical and microscopic features improves prognostication of patients with osteosarcoma.

Entities:  

Year:  2016        PMID: 27552092     DOI: 10.5858/arpa.2015-0389-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  14 in total

1.  CORR Insights®: Are Biopsy Tracts a Concern for Seeding and Local Recurrence in Sarcomas?

Authors:  Michelle Ghert
Journal:  Clin Orthop Relat Res       Date:  2016-10-06       Impact factor: 4.176

2.  T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.

Authors:  Lawrence M White; Angela Atinga; Ali M Naraghi; Katherine Lajkosz; Jay S Wunder; Peter Ferguson; Kim Tsoi; Anthony Griffin; Masoom Haider
Journal:  Skeletal Radiol       Date:  2022-07-01       Impact factor: 2.199

3.  Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade.

Authors:  Julie E Stein; Evan J Lipson; Tricia R Cottrell; Patrick M Forde; Robert A Anders; Ashley Cimino-Mathews; Elizabeth D Thompson; Mohamad E Allaf; Mark Yarchoan; Josephine Feliciano; Hao Wang; Elizabeth M Jaffee; Drew M Pardoll; Suzanne L Topalian; Janis M Taube
Journal:  Clin Cancer Res       Date:  2019-10-31       Impact factor: 12.531

Review 4.  P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA.

Authors:  Yin Tang; Changchun Yang; Zonghui Guo; Youwei Fu; Xiao Yu; Binggen Liu; Haier Zhou; Junjie Wang; Weilong Li; Qingjiang Pang
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

5.  CONUT Score or/and Peripheral Blood CD4+/CD8+ Ratio-Based Web Dynamic Nomograms to Predict the Individualized Survival of Patients with Advanced Osteosarcoma.

Authors:  Qian-Kun Yang; Yan-Na Su; Wei Wang; Zhong-Xiang Yao; Nan Wang; Xiao-Jing Zhang
Journal:  Cancer Manag Res       Date:  2020-06-03       Impact factor: 3.989

6.  Wnt signaling and Loxl2 promote aggressive osteosarcoma.

Authors:  Kazuhiko Matsuoka; Latifa Bakiri; Lena I Wolff; Markus Linder; Amanda Mikels-Vigdal; Ana Patiño-García; Fernando Lecanda; Christine Hartmann; Maria Sibilia; Erwin F Wagner
Journal:  Cell Res       Date:  2020-07-20       Impact factor: 25.617

7.  Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study.

Authors:  Yogi Prabowo; Iwan Setiawan; Achmad Fauzi Kamal; Evelina Kodrat; Muhammad Luqman Labib Zufar
Journal:  Int J Surg Oncol       Date:  2021-04-26

8.  Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes.

Authors:  Yi-Jiang Song; Yanyang Xu; Chuangzhong Deng; Xiaojun Zhu; Jianchang Fu; Hongmin Chen; Jinchang Lu; Huaiyuan Xu; Guohui Song; Qinglian Tang; Jin Wang
Journal:  Front Immunol       Date:  2021-04-20       Impact factor: 7.561

9.  Is Microscopic Vascular Invasion in Tumor Specimens Associated with Worse Prognosis in Patients with High-grade Localized Osteosarcoma?

Authors:  Yusuke Tsuda; Kim Tsoi; Jonathan D Stevenson; Michael C Parry; Tomohiro Fujiwara; Vaiyapuri Sumathi; Lee M Jeys
Journal:  Clin Orthop Relat Res       Date:  2020-06       Impact factor: 4.755

10.  Prediction and evaluation of neoadjuvant chemotherapy using the dual mechanisms of 99mTc-MIBI scintigraphy in patients with osteosarcoma.

Authors:  Caixia Wu; Qian Wang; Yuan Li
Journal:  J Bone Oncol       Date:  2019-07-09       Impact factor: 4.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.